1. Home
  2. PODD

PODD

Insulet Corporation

Logo Insulet Corporation

Health Care

Medical/Dental Instruments

Nasdaq

as 04-19-2024 4:00pm EST

$
-
-
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it worldwide.

Founded: 2000 Country:
United States
United States
Employees: N/A City: ACTON
Market Cap: 12.1B IPO Year: 2007
Target Price: $256.87 AVG Volume (30 days): 864.6K
Analyst Decision: Buy Number of Analysts: 15
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: 2.94 EPS Growth: 4100.00
52 Week Low/High: $125.82 - $335.91 Next Earning Date: 05-09-2024
Revenue: $1,697,100,000 Revenue Growth: 30.02%
Revenue Growth (this year): 17.91% Revenue Growth (next year): 18.54%

Share on Social Networks:

Stock Insider Trading Activity of Insulet Corporation (PODD)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Petrovic Shacey PODD Director Feb 28 '24 Sell $162.92 11,609 $1,891,338.28 2,567 SEC Form 4
BORIO LUCIANA PODD Director Dec 15 '23 Sell $207.08 72 $14,909.76 2,278 SEC Form 4
Petrovic Shacey PODD Director Nov 13 '23 Sell $165.02 2,075 $342,416.50 41,130 SEC Form 4
Petrovic Shacey PODD Director Nov 13 '23 Sell $165.02 12,925 $2,132,883.50 0 SEC Form 4
Petrovic Shacey PODD Director Nov 13 '23 Sell $164.33 20,000 $3,286,600.00 2,567 SEC Form 4